← boothcheck

KEYS vs TER stock comparison

KEYSIGHT TECHNOLOGIES, INC. vs TERADYNE, INC., two Scientific Instruments stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Two test-and-measurement franchises, two different bets in the multiple: Teradyne at 80.9 times earnings is priced for the AI chip-test cycle to keep steepening, Keysight at 54.5 times for design-and-network test demand that grows without theatrics. The economics rank the same way, Teradyne's 36.9% operating margin over Keysight's 23.7%, returns on assets of 19.3% against 9%. Keysight converts nearly three times the price into free cash, 2.4% to 0.8%, and carries the only real leverage, a mild 0.51. Both prices assume electronics complexity keeps compounding; only one needs this particular cycle to stay vertical. The premium on the steeper story is 26 turns.

Comparison updated 2026-07-10.

KEYS vs TER: the numbers

MetricKEYSTER
Price$332.63$435.82
Market cap$57.5B$68.7B
SectorScientific InstrumentsScientific Instruments
StageGrowthGrowth
P/E54.580.9
P/B9.0921.85
P/S9.4518.14
EV/EBITDA51.060.4
Revenue growth+19.0%+31.1%
Gross margin60.9%
Operating margin23.7%36.9%
Net margin17.3%22.6%
Return on equity16.6%27.2%
Return on assets9.0%19.3%
Return on invested capital9.7%27.6%
FCF yield2.4%0.8%
Dividend yield0.1%
Debt / equity0.510.00
Current ratio1.902.15
Altman Z (solvency)7.807.87
Piotroski F (quality)8 / 96 / 9
Full KEYS report → Full TER report →
Get boothcheck's read on KEYS and TER, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.